13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • ePAD

    Acronym: 

    ePAD

    ACTRN/NCT /ethics: 

    Scientific title: 

    Summary of trial and patient characteristics

    Cancer Type Prostate
    Trial Type Early detection, diagnosis, prognosis
    Phase Tumour Stream Prostate
    Age Range 18 years and older Cancer Stage Locally Recurrent or Locally Advanced
    Sex Male Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Prostate
    Trial Type Early detection, diagnosis, prognosis
    Phase
    Age Range 18 years and older
    Sex Male
    Molecular Target
    Tumour Stream Prostate
    Cancer Stage Locally Recurrent or Locally Advanced
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    Electronic CRPC Australian Database (ePAD): Analyzing treatment patterns and outcomes from real-world patients with castrate-resistant prostate cancer

    Lay Summary

    Sponsor / Cooperative group

    Melb Health

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Ashford Cancer Centre Research Helen Daykin hdaykin@adelaidecancercentre.com.au 08 8292 2240 Recruiting